Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Videos

The pediatric neurologist at Duke Health and chief executive officer at Theranica talked about a remote electrical neuromodulation wearable that showed promising results for the treatment and prevention of migraine in pediatric patients. [WATCH TIME: 5 minutes]

Advancing the Treatment of Pediatric Migraine With Nerivio REN Wearable: Klaus Werner, MD & Alon Ironi

Articles

AL002 did not meet the primary endpoint of slowing Alzheimer's clinical progression, as measured by the Clinical Dementia Rating Sum of Boxes and showed no treatment effects on secondary clinical and functional endpoints.

AL002 Falls Short in Phase 2 INVOKE-2 Trial of Early Alzheimer Disease

The cofounder and chief science officer of the Alzheimer's Drug Discovery Foundation highlighted the critical role of collaboration and innovative diagnostics for advancing Alzheimer disease care. [WATCH TIME: 4 minutes]

Collaboration and Innovation in Alzheimer Disease Clinical Trial Research: Howard Fillit, MD

Over 1 year of treatment, simufilam failed to distinguish itself from placebo on the primary end points of Alzheimer’s Disease Assessment Scale-Cognitive Subscale 12 and Alzheimer’s Disease Cooperative Study-Activities of Daily Living.

Alzheimer Agent Simufilam Fails to Meet Primary End Point in Phase 3 Study

Here's the latest multidisciplinary multiple sclerosis (MS) research from the International Journal of MS Care.

Research from IJMSC October 2024

The neurologist in the Headache Center at Cleveland Clinic shared her post perspective on the 2024 AHS Scottsdale meeting which highlighted advancements in headache medicine and the growing impact of the field on patient care. [WATCH TIME: 5 minutes]

Highlights on Exploring Advances in Headache Medicine from AHS Scottsdale 2024: MaryAnn Mays, MD

The epilepsy specialist and Cleveland Clinic’s Chief Research and Information Officer discussed the wide-spread applicability of scalp EEG and the potential for machine learning models to help predict epilepsy surgery outcomes. [WATCH TIME: 4 minutes]

Scalability of Scalp EEG as a Tool for Epilepsy Surgery Outcomes: Lara Jehi, MD, MHCDS

Dean and chief academic officer at the University of Miami Miller School of Medicine.

The dean and chief academic officer at the University of Miami Miller School of Medicine discussed the university’s investment in computational biology to advance aging and neuroscience research. [WATCH TIME: 5 minutes]

Driving Innovation in Aging and Neurodegenerative Research: Henri Ford, MD, MHA 

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AANEM 2024

CTAD 2024

MDS 2024

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

Continuing Education

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis - Current Treatment and Emerging Concepts

Colleen Buhrfiend, MD; Timothy Benke, MD, PhD; Anita Datta, MD, FRCPC, CSCN Diplomate (EEG)

Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes

2024 Neuromuscular Summit

Jessica Ailani, MD, FAHS, FAAN; Richard S. Isaacson, MD; Stephen Krieger, MD, FAAN; Rory M. C. Abrams, MD; Laxman Bahroo, DO; Richard S. Bedlack Jr, MD, PhD, MS; Patricia K. Coyle, MD; Gayatri Devi, MD, MS, FACP, FAAN; Patricia Dugan, MD, FAES; Mazen Elkurd, DO; Jill Farmer, DO, MPH; Jennifer A. Frontera, MD; Saadi Ghatan, MD, FACS; Jihan A. Grant, MD; Stuart Isaacson, MD, FAAN; Steven E. Lo, MD; Erin Longbrake, MD, PhD; Lara V. Marcuse, MD; Kara R. Melmed, MD; Matthew Schrag, MD, PhD; Stewart Tepper, MD;

5th Annual International Congress on the Future of Neurology®

Leslie Citrome, MD, MPH; Roger S. McIntyre MD, FRCPC

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

Nicholas J. Silvestri, MD; James F. Howard Jr, MD

Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management

Leslie Citrome, MD, MPH; Joseph F Goldberg, MD; Manish Kumar Jha, MBBS

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

Burst CME: Optimizing Therapy in Parkinson’s Disease

Leslie Citrome, MD, MPH; Charles Brendan Montano, MD

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

Stephen Krieger, MD, FAAN; Mitzi Joi Williams, MD, FAAN; Frauke Zipp, MD

Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors

James F. Howard Jr, MD; Nicholas J. Silvestri, MD

Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders

Jakai D. Nolan, DO, MPH; Mitzi Joi Williams, MD, FAAN

Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients

Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis

Burst Expert Illustrations & Commentary™:  Visualizing the Role of the Complement Pathway in Neurological Disorders

Individualizing Treatment for Patients with Generalized Myasthenia Gravis

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

Terry D. Heiman-Patterson, MD; Anahita Deboo, MD

Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care

James F. Howard Jr, MD, FAAN; Nicholas J. Silvestri, MD, FAAN

Burst Expert Illustrations & Commentary™: Visualizing the Role of FcRN in Neurological Disorders

BURST Expert Illustrations and Commentaries™: Visualizing FcRn as a Therapeutic Target in Neurological Disease

BURST Expert Illustrations and Commentaries™: Visualizing the Implications of FcRN-Targeted Therapies on Generalized Myasthenia Gravis

Nicholas J. Silvestri, MD, FAAN; Neelam Goyal, MD

Clinical Consultations™: Navigating the Evolving Treatment Landscape in Generalized Myasthenia Gravis

Dani Cabral, MD; Marwan N. Sabbagh, MD, FAAN, FANA

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

Burst Expert Illustrations & Commentary™: Visualizing the Role of Subcutaneous Infusion as an Alternate Administration Route for Medical Interventions

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Sanjai Rao, MD, DFAPA; Jonathan M. Meyer, MD

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

Daniel Claassen, MD, MS; Martha A. Nance, MD

 Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

SimulatEd™ From Discomfort to Relief: Acute Pain Management Essentials

Alireza Atri, MD, PhD; Erik S. Musiek, MD, PhD; Malú Gámez Tansey, PhD


Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

Carrie M. Hersh, DO, MSc, FAAN; Anna Shah, MD

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

James F. Howard Jr, MD; Nicholas J. Silvestri, MD, FAAN; Neelam Goyal, MD

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

Jessica Ailani, MD, FAHS, FAAN; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Erik S. Musiek, MD, PhD; Malú Gámez Tansey, PhD

 Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

Alejandro Alva, MD; Linda Trinh, DNP, PMHNP, FNP, MPH

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Upcoming CME Events & Activities

EVENTS

ACTIVITIES